Shimadzu Spring Show Guide - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Shimadzu Spring Show Guide


Shimadzu Scientific Instruments (SSI) offers a full line of analytical measurement and testing solutions for every aspect of the pharmaceutical pipeline, from life science research and drug discovery/development to manufacturing and QA/QC. Products include chromatographs (HPLC/UHPLC, GC); mass spectrometers (GC/MS/MS, LC/MS/MS, MALDI); spectrophotometers (FT-IR, Fluorescence, UV-VIS-NIR); atomic/X-ray spectrometers; thermal analyzers; Total Organic Carbon (TOC) analyzers; particle size analyzers; balances; and materials testers.

E-mail: webmaster@shimadzu.com

Website: www.ssi.shimadzu.com

Shows attending:

  • Pittcon — booth 1434
  • ACS — booth 617

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here